Updated on : 03-03-2025
| The purpose of the "Regulations on the Supervision and Administration of Drug Production for Export" is to regulate the drug manufacturing activities of Chinese manufacturers exporting drugs to other countries or regions, and to require the implementation of GMP. It mainly includes the following contents: general provisions, basic requirements, entrusted manufacturing for export, export drug archives, export certification documents (general requirements for export certification documents, Certificate of a Pharmaceutical product, Written confirmation for active substances exported to EU), supervision and management, and supplementary provisions. |
| Title | Category | Created On |
|---|---|---|
| Participation in the fair titled The 10th China- South Asia Expo and The 30th China Kunming Import and Export Fair-2026 in Kunming, China from June 11-16, 2026 | Trade | 2026-03-11 04:09:52 |
| Regarding participation in the fair titled “South Asia Trade Fair 2026” in Kathmandu, Nepal from 7-12 May 2026 | Trade | 2026-03-09 03:56:08 |
| Regarding participation in the fair titled “SEMICON Southeast Asia-2026” to be held in Kuala Lumpur, Malaysia from May 5-7, 2026 | Trade | 2026-03-04 03:32:11 |
| Regarding participation in the fair titled "21st Lifestyle Week Tokyo" from June 24-26, 2026 | Trade | 2026-02-25 04:38:08 |
| USA: Parts and Accessories Necessary for Safe Operation; Fuel Tank Overfill Restriction | TBT | 2026-02-23 07:45:02 |